<DOC>
	<DOCNO>NCT01153659</DOCNO>
	<brief_summary>This randomize , open-label , single-center , 3-way crossover study healthy subject confirm Helicobacter pylorus ( H. pylorus ) -negative . The study consist 3 study period separate washout period least 7 day . Subjects receive study drug daily 5 day . Barring safety concern , subject discharge study Day 6 Period 3 completion discharge procedure .</brief_summary>
	<brief_title>A Study Evaluate Effect 24-hour , Intragastric pH RAB ER 50-mg Capsules Compared With Esomeprazole ( Nexium ) 40 mg Capsules Rabeprazole ( Aciphex ) 20-mg Tablets</brief_title>
	<detailed_description />
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Key inclusion : Healthy male female subject , include woman childbearing potential , age 18 55 year , inclusive Subjects able tolerate insertion placement pH probe 2 occasion per study period ( Day 1 Day 5 ) Key Exclusion : Subjects H. pyloripositive Subjects history gastrointestinal disorder surgery likely influence drug absorption ( e.g. , history gastric resection ) Known hypersensitivity rabeprazole , esomeprazole , related compound ingredient formulation Other standard clinical pharmacology exclusion criterion healthy volunteer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>rabeprazole</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>h. pylori-negative</keyword>
	<keyword>nocturnal acid breakthrough</keyword>
	<keyword>intragastric pH , PK/PD</keyword>
	<keyword>effect gastric pH healthy , H. pylori-Negative subject</keyword>
</DOC>